NANJING PHARMACEUTICAL COMPANY LIMITEDNANJING PHARMACEUTICAL COMPANY LIMITEDNANJING PHARMACEUTICAL COMPANY LIMITED

NANJING PHARMACEUTICAL COMPANY LIMITED

No trades
See on Supercharts

600713 fundamentals

NANJING PHARMACEUTICAL COMPANY LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 600713 for the last quarter is 13.68 B CNY, and it's 3.21% higher compared to the previous quarter. The net income of Q3 24 is 130.56 M CNY.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth